ChartRow logo
ChartRow
Stocks and ETFs
Sign in
VRTX
Vertex Pharmaceuticals IncorporatedStock · Healthcare
$528.04+$30.03 (+6.03%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Vertex Pharmaceuticals makes money

Fiscal year

How does Vertex Pharmaceuticals make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year. Straight from SEC filings.

Vertex Pharmaceuticals Incorporated · FY2025 · year ended 2025-12-31
Revenue$12.1BGross profit$10.3B · 86%Cost of revenue$1.7B · 14%Operating income$4.2B · 35%Operating expenses$6.2B · 51%R&D$3.9B · 33%SG&A$1.8B · 15%Other opex$514M · 4%Pre-tax income$4.6B · 39%Other income$470M · 4%Net income$4.0B · 33%Income tax$690M · 6%TRIKAFTAKAFTRIO$10.3B · 86%ALYFTREK$838M · 7%Manufactured Product Other$820M · 7%CASGEVY$116M · 1%JOURNAVX$60M · 0%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.